August 27, 2026
The report analyses the biosimilars market based on market key takeaways, market overview, market trends & future outlook, segmental insights, regional insights, top vendors, and recent developments. The analysis was led by Payal Rabde, Senior Re...
April 21, 2026
Projections indicate that, the global aflibercept biosimilars market will increase from USD 1.54 billion in 2024 to USD 3.7 billion by 2034, experiencing a CAGR of 9.14% over the next 10 years. The maturing ophthalmic biosimilar ecosystem is estimate...
October 05, 2026
According to Payal Rabde, who specializes in the development, manufacturing, and commercialization of biologic medicines, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities...